Joint association of the composite cholesterol-high-density lipoprotein-glucose index and psychological burden with prevalent cardiometabolic multimorbidity: integrating lipid, glycemic, and psychological dimensions

Cardiometabolic multimorbidity (CMM) is closely associated with various metabolic factors, including lipid metabolism disorders, abnormal glucose metabolism, and insulin resistance. With the development of metabolic psychiatry, the relationship between metabolic abnormalities and mental health has attracted increasing attention, highlighting the importance of considering both metabolic factors and psychological burden in the comprehensive assessment of CMM. The cholesterol-high-density lipoprotein-glucose (CHG) index is a novel indicator of metabolic burden derived from total cholesterol, high-density lipoprotein cholesterol, and fasting blood glucose levels. This study aimed to investigate the joint association of the CHG index and depressive symptoms with prevalent CMM. We analyzed data from adults from the 2005–2018 National Health and Nutrition Examination Survey. The CHG index was calculated using total cholesterol, high-density lipoprotein cholesterol, and fasting glucose levels. Psychological burden was assessed using the 9-item Patient Health Questionnaire (PHQ-9), with a score ≥ 10 indicating clinically relevant depressive symptoms. CMM was defined as having at least two cardiometabolic conditions, including diabetes, coronary heart disease, and stroke. Among 12,786 participants (median age, 47 years; 51.03% women), a higher CHG index (adjusted OR = 1.87, 95% CI: 1.47–2.37) and clinically relevant depressive symptoms (adjusted OR = 2.36, 95% CI: 1.74–3.21) were each associated with higher odds of CMM. In the joint analysis, compared with participants with a CHG index < 5.22 and a PHQ-9 score < 10, participants with both a higher CHG index and clinically relevant depressive symptoms had higher odds of CMM (adjusted OR = 4.43, 95% CI: 2.96–6.64). ROC analysis revealed that the combined model had the highest AUC (0.913, 95% CI: 0.901–0.925). Relative to the base model, the combined model yielded a continuous NRI of 0.603 (95% CI: 0.488–0.717) and an IDI of 0.028 (95% CI: 0.012–0.044). These findings suggest modest incremental discrimination of prevalent CMM. Our findings indicate that individuals with both an elevated CHG index and clinically relevant depressive symptoms have higher odds of prevalent CMM. Combined consideration of lipid dysregulation, glycemic abnormalities, and depressive symptom burden may provide complementary information for​​​​​​ identifying​ individuals with prevalent CMM.

Authors

Institutions

Publication Details

Journal
Lipids in Health and Disease
Published
2026-11-18
DOI
https://doi.org/10.1186/s12944-026-03123-w
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Joint association of the composite cholesterol-high-density lipoprotein-glucose index and psychological burden with prevalent cardiometabolic multimorbidity: integrating lipid, glycemic, and psychological dimensions

Ningkun Xiao, Qingzhi Zhou, Haonan Ju, Xiangpeng Kong et al.
9 links
Lipids in Health and Disease
Chronic Disease Management Strategies
article

Joint association of the composite cholesterol-high-density lipoprotein-glucose index and psychological burden with prevalent cardiometabolic multimorbidity: integrating lipid, glycemic, and psychological dimensions

Ningkun Xiao, Qingzhi Zhou, Haonan Ju, Xiangpeng Kong, Yan Chen, Xin Zhao
article en

Abstract

Cardiometabolic multimorbidity (CMM) is closely associated with various metabolic factors, including lipid metabolism disorders, abnormal glucose metabolism, and insulin resistance. With the development of metabolic psychiatry, the relationship between metabolic abnormalities and mental health has attracted increasing attention, highlighting the importance of considering both metabolic factors and psychological burden in the comprehensive assessment of CMM. The cholesterol-high-density lipoprotein-glucose (CHG) index is a novel indicator of metabolic burden derived from total cholesterol, high-density lipoprotein cholesterol, and fasting blood glucose levels. This study aimed to investigate the joint association of the CHG index and depressive symptoms with prevalent CMM. We analyzed data from adults from the 2005–2018 National Health and Nutrition Examination Survey. The CHG index was calculated using total cholesterol, high-density lipoprotein cholesterol, and fasting glucose levels. Psychological burden was assessed using the 9-item Patient Health Questionnaire (PHQ-9), with a score ≥ 10 indicating clinically relevant depressive symptoms. CMM was defined as having at least two cardiometabolic conditions, including diabetes, coronary heart disease, and stroke. Among 12,786 participants (median age, 47 years; 51.03% women), a higher CHG index (adjusted OR = 1.87, 95% CI: 1.47–2.37) and clinically relevant depressive symptoms (adjusted OR = 2.36, 95% CI: 1.74–3.21) were each associated with higher odds of CMM. In the joint analysis, compared with participants with a CHG index < 5.22 and a PHQ-9 score < 10, participants with both a higher CHG index and clinically relevant depressive symptoms had higher odds of CMM (adjusted OR = 4.43, 95% CI: 2.96–6.64). ROC analysis revealed that the combined model had the highest AUC (0.913, 95% CI: 0.901–0.925). Relative to the base model, the combined model yielded a continuous NRI of 0.603 (95% CI: 0.488–0.717) and an IDI of 0.028 (95% CI: 0.012–0.044). These findings suggest modest incremental discrimination of prevalent CMM. Our findings indicate that individuals with both an elevated CHG index and clinically relevant depressive symptoms have higher odds of prevalent CMM. Combined consideration of lipid dysregulation, glycemic abnormalities, and depressive symptom burden may provide complementary information for​​​​​​ identifying​ individuals with prevalent CMM.

Lipids in Health and Disease
Ural Federal University (RU), Dalian Medical University (CN), Second Affiliated Hospital of Dalian Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Chronic Disease Management Strategies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon